Septerna (SEPN) Research & Development (2023 - 2026)
Septerna (SEPN) recorded quarterly Research & Development of $29.5 million in Q1 2026, down 7.3% quarter-over-quarter from $31.9 million in Q4 2025, and up 53.26% on a YoY basis from $19.3 million in Q1 2025.
Septerna (SEPN) Research & Development (2023 - 2026) Analysis & Trends
Septerna's Research & Development history runs 4 years deep, the most recent figure standing at $29.5 million for Q1 2026.
- In Q1 2026, Research & Development rose 53.26% year-over-year to $29.5 million; the TTM figure through Mar 2026 stood at $107.8 million (up 50.93% YoY), while the FY2025 annual figure was $97.6 million, up 49.35% from the prior year.
- Research & Development was $29.5 million for Q1 2026 at Septerna, down from $31.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $31.9 million in Q4 2025 to a low of $9.3 million in Q3 2023.
- Historically, Research & Development has averaged $19.3 million across 4 years, with a median of $19.3 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Research & Development surged 92.13% in 2024, then surged 36.07% in 2025.
- A 4-year view of Research & Development shows it stood at $10.3 million in 2023, then soared by 87.07% to $19.3 million in 2024, then jumped by 64.94% to $31.9 million in 2025, then fell by 7.3% to $29.5 million in 2026.
- The last three Research & Development figures came in at $29.5 million (Q1 2026), $31.9 million (Q4 2025), and $24.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 29.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.54 Mn |
| Dec 31, 2025 | 31.86 Mn |
| Sep 30, 2025 | 24.26 Mn |
| Jun 30, 2025 | 22.19 Mn |
| Mar 31, 2025 | 19.27 Mn |
| Dec 31, 2024 | 19.32 Mn |
| Sep 30, 2024 | 17.83 Mn |
| Jun 30, 2024 | 15.04 Mn |
| Mar 31, 2024 | 13.15 Mn |
| Dec 31, 2023 | 10.33 Mn |
| Sep 30, 2023 | 9.28 Mn |